## IR: Ingersoll Rand Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.2% below STRENGTH zone (3.0-6.0%); PEG 1.05 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference**
- Source: ValleyCentral.com | 20251222T140810 | Neutral | Relevance: 100%
- Ingersoll Rand Inc. (NYSE: IR) announced that its leadership team, including CEO Vicente Reynal, CFO Vik Kini, and SVP Scott Watson, will present at the 2026 J.P. Morgan Healthcare Conference on January 14, 2026, at 7:30 a.m. Pacific Time. A real-time audio webcast of the fireside chat will be accessible via the company's Investor Relations website, with a replay available afterward. The company provides mission-critical flow creation and life science and industrial solutions globally.

**2. CCLA Investment Management Has $113.57 Million Stake in Ingersoll Rand Inc. $IR**
- Source: MarketBeat | 20251222T100928 | Neutral | Relevance: 100%
- CCLA Investment Management significantly increased its stake in Ingersoll Rand Inc. (NYSE:IR) by 19.5% during the third quarter, bringing its total holdings to 1,374,884 shares valued at approximately $113.57 million. Other institutional investors also adjusted their positions, and Ingersoll Rand reported Q3 EPS of $0.86, missing estimates slightly, with revenue up 5.1% year-over-year. The company trades at a P/E of 58.7 with a consensus "Hold" rating and a target price of $91.44.

**3. Texas Permanent School Fund Corp Sells 15,236 Shares of Ingersoll Rand Inc. $IR**
- Source: MarketBeat | 20251221T103002 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Ingersoll Rand Inc. by 34.9%, selling 15,236 shares, though still holding shares valued at over $2.36 million. The company's stock currently holds a "Hold" rating from analysts with a consensus target price of $91.44, while its Q3 earnings missed estimates by a narrow margin. Insider Michael J. Scheske also sold a portion of his shares, reducing his ownership by over 10%.

**4. Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference**
- Source: WDHN | 20251222T130826 | Somewhat-Bullish | Relevance: 100%
- Ingersoll Rand Inc. announced that its Chairman and CEO Vicente Reynal, CFO Vik Kini, and SVP Scott Watson will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation, a fireside chat, is scheduled for Wednesday, January 14, 2026, at 7:30 a.m. Pacific Time, and will be webcast live on the company's investor relations website. Ingersoll Rand is a global provider of mission-critical flow creation and life science and industrial solutions.

**5. Vontier (VNT): Assessing Valuation After Driivz Gains Key EV Charging Accessibility Network Qualification**
- Source: Simply Wall Street | 20251222T150926 | Neutral | Relevance: 65%
- Vontier's subsidiary, Driivz, has achieved a significant qualification for its EV charging accessibility network, positioning Vontier for growth in the public-sector EV market. Despite recent stock fluctuations, Vontier is considered undervalued by analysts, trading below target prices with double-digit earnings growth, especially in its SaaS and recurring services. The article explores whether the market is fully recognizing Vontier's potential in the EV and mobility sector.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $81 | $75 | +8% |
| 2025-12-08 | Citigroup | $94 | $91 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Hold |
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 66.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Capital Internationa: 12.7% (+18.5%)
- Vanguard Group Inc: 11.5% (-3.7%)
- Capital World Invest: 8.1% (+19.2%)
- Blackrock Inc.: 7.5% (-6.7%)
- JPMORGAN CHASE & CO: 6.3% (+36.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Forward P/E 22.8x stretched relative to 9% growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment positive (2 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.4B |
| Beta | 1.33 |
| 52W Range | $65.61 - $95.85 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 22.8 |
| Current P/E | 24.8 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.2% (minimal 5-day change). Below STRENGTH zone by 3.2pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.6%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.25% (CS: 64) | Neutral |
| RSI_14 | 57.2 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.018x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $81.46
- **Stop Loss:** $77.64 (4.7% risk)
- **Target:** $85.28 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 235
- **Position Value:** $19,143.10
- **Portfolio %:** 19.14%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-12 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.86 | $0.86 | -0.3% |
| 2025Q2 | $0.80 | $0.80 | +0.2% |
| 2025Q1 | $0.74 | $0.72 | -2.3% |
| 2024Q4 | $0.84 | $0.84 | -0.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*